|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3885035A
(en)
|
1972-04-05 |
1975-05-20 |
Sandoz Ag |
Method for treating arrhythmia by using 1,4-bis(4 quinazolinyl) piperazines
|
|
US3956495A
(en)
|
1973-10-30 |
1976-05-11 |
Eli Lilly And Company |
2,4-Diaminoquinazolines as antithrombotic agents
|
|
US3966936A
(en)
|
1974-02-21 |
1976-06-29 |
Pfizer Inc. |
Piperazino quinazoline bronchodilators
|
|
US4060615A
(en)
|
1976-02-18 |
1977-11-29 |
Mead Johnson & Company |
2-Piperazinyl-6,7-dimethoxyquinazolines
|
|
JPS562968A
(en)
|
1979-06-21 |
1981-01-13 |
Mitsubishi Yuka Yakuhin Kk |
Novel pyrimidine derivative
|
|
JPS6270A
(ja)
|
1985-03-07 |
1987-01-06 |
Sankyo Co Ltd |
シクロペンタ〔ｄ〕ピリミジン誘導体
|
|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
DE3752141T2
(de)
|
1986-02-24 |
1998-03-26 |
Mitsui Petrochemical Ind |
Mittel zur behandlung von neuropathie
|
|
US4871739A
(en)
|
1987-01-21 |
1989-10-03 |
Merck & Co., Inc. |
Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
|
|
US4889856A
(en)
|
1987-08-31 |
1989-12-26 |
Merck & Co., Inc. |
7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers
|
|
US4994464A
(en)
|
1987-08-31 |
1991-02-19 |
Merck & Co., Inc. |
Piperazinylpyrimidines as β-adrenergic receptor blockers
|
|
WO1990007926A1
(en)
|
1989-01-20 |
1990-07-26 |
Pfizer Inc. |
3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
|
|
KR100262254B1
(ko)
|
1992-10-05 |
2000-07-15 |
나카히로 마오미 |
피리미딘 화합물
|
|
EP0710654A4
(en)
|
1993-07-23 |
1996-08-28 |
Green Cross Corp |
TRIAZOLE DERIVATIVE AND ITS PHARMACEUTICAL USE
|
|
GB9416189D0
(en)
|
1994-08-10 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
RU2129549C1
(ru)
|
1994-08-13 |
1999-04-27 |
Юхан Корпорейшн |
Производные пиримидина и способы их получения
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
US5525625A
(en)
|
1995-01-24 |
1996-06-11 |
Warner-Lambert Company |
2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
|
|
JPH08336393A
(ja)
|
1995-04-13 |
1996-12-24 |
Mitsubishi Chem Corp |
光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
|
|
US7125880B1
(en)
|
1995-06-06 |
2006-10-24 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
ZA979961B
(en)
|
1996-11-15 |
1999-05-05 |
Lilly Co Eli |
5-HT1F agonists
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6506798B1
(en)
|
1997-07-01 |
2003-01-14 |
Warner-Lambert Company |
4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
|
|
BR9810366A
(pt)
|
1997-07-01 |
2000-08-29 |
Warner Lambert Co |
Derivados de ácido 4-bromo ou 4-iodo fenilamino benzidroxîmico e seu uso como inibidores de mek
|
|
US6310060B1
(en)
|
1998-06-24 |
2001-10-30 |
Warner-Lambert Company |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
NZ501277A
(en)
|
1997-07-01 |
2002-12-20 |
Warner Lambert Co |
-2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
US6821963B2
(en)
|
1997-07-01 |
2004-11-23 |
Warner-Lambert Company |
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
|
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
WO1999051582A1
(en)
|
1998-03-31 |
1999-10-14 |
Kyowa Hakko Kogyo Co., Ltd. |
Nitrogenous heterocyclic compounds
|
|
DE19853278A1
(de)
|
1998-11-19 |
2000-05-25 |
Aventis Pharma Gmbh |
Substituierte 4-Amino-2-aryl-cyclopenta[d]pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
ATE292462T1
(de)
|
1999-01-07 |
2005-04-15 |
Warner Lambert Co |
Behandlung von asthma anhand von mek-inhibitoren
|
|
HUP0104933A3
(en)
|
1999-01-07 |
2003-12-29 |
Warner Lambert Co |
Antiviral method using mek inhibitors
|
|
IL144214A0
(en)
|
1999-01-13 |
2002-05-23 |
Warner Lambert Co |
Benzoheterocycles and their use as mek inhibitors
|
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
|
ES2252996T3
(es)
|
1999-01-13 |
2006-05-16 |
Warner-Lambert Company Llc |
Derivados de bencenosulfonamida y su uso como inhibidores de mek.
|
|
IL144215A0
(en)
|
1999-01-13 |
2002-05-23 |
Warner Lambert Co |
1-heterocycle substituted diarylamines
|
|
ATE311363T1
(de)
|
1999-01-13 |
2005-12-15 |
Warner Lambert Co |
Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
|
|
BR9916857A
(pt)
|
1999-01-13 |
2001-12-04 |
Warner Lambert Co |
4 heteroaril diarilaminas
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
AU5785900A
(en)
|
1999-07-16 |
2001-02-05 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
EP1202726A2
(en)
|
1999-07-16 |
2002-05-08 |
Warner-Lambert Company Llc |
Method for treating chronic pain using mek inhibitors
|
|
PL352835A1
(en)
|
1999-07-16 |
2003-09-08 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
HUP0202180A3
(en)
|
1999-07-16 |
2004-10-28 |
Warner Lambert Co |
Method for treating chronic pain using mek inhibitors
|
|
BR0109188A
(pt)
|
2000-03-15 |
2003-03-18 |
Warner Lambert Co |
Diarilaminas 5-amida substituìdas como inibidores de mex
|
|
YU2503A
(sh)
|
2000-07-19 |
2006-05-25 |
Warner-Lambert Company |
Oksigenovani estri 4-jodo fenilamino benzhidroksamskih kiselina
|
|
JP2004507518A
(ja)
|
2000-08-25 |
2004-03-11 |
ワーナー−ランバート・カンパニー・エルエルシー |
Ｎ−アリール−アントラニル酸及びその誘導体の製造法
|
|
JP2004509115A
(ja)
|
2000-09-15 |
2004-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとして有用なピラゾール化合物
|
|
AU2002210714A1
(en)
|
2000-11-02 |
2002-06-11 |
Astrazeneca Ab |
Substituted quinolines as antitumor agents
|
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
ATE386727T1
(de)
|
2001-04-30 |
2008-03-15 |
Glaxo Group Ltd |
Kondensierte pyrimidine als antagonisten des corticotropin releasing factor (crf)
|
|
US7115741B2
(en)
|
2001-09-06 |
2006-10-03 |
Levy Daniel E |
4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds
|
|
JP4391825B2
(ja)
|
2001-12-06 |
2009-12-24 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
EP1470121B1
(en)
|
2002-01-23 |
2012-07-11 |
Bayer HealthCare LLC |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
TWI350285B
(en)
|
2002-03-13 |
2011-10-11 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
CA2478534A1
(en)
|
2002-03-13 |
2003-09-25 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
|
EP1496896A4
(en)
|
2002-04-08 |
2007-10-31 |
Merck & Co Inc |
AKT INHIBITORS EFFECT
|
|
CA2480880C
(en)
|
2002-04-08 |
2011-03-22 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
AU2003226250B2
(en)
|
2002-04-08 |
2007-08-16 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
AU2003226271B2
(en)
|
2002-04-08 |
2007-10-18 |
Merck Sharp & Dohme Corp. |
Fused quinoxaline derivatives as inhibitors of Akt activity
|
|
MXPA04011093A
(es)
|
2002-05-10 |
2005-02-14 |
Neurocrine Biosciences Inc |
Piperazina sustituida como ligandos de receptores de melanocortina.
|
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
AU2003284981B2
(en)
|
2002-10-30 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
RS20050363A
(sr)
|
2002-11-28 |
2007-11-15 |
Schering Aktiengesellschaft, |
Chk-,Pdk- I Akt-INHIBITORNI PIRIMIDINI, NJIHOVA PROIZVODNJA I UPOTREBA KAO FARMACEUTSKIH SREDSTAVA
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP1620095A4
(en)
|
2003-04-24 |
2009-04-01 |
Merck & Co Inc |
HEMMER OF ACT ACTIVITY
|
|
WO2004111014A1
(en)
|
2003-06-06 |
2004-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
EP1663994B1
(en)
|
2003-08-05 |
2012-03-07 |
Vertex Pharmaceuticals Incorporated |
Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
|
|
DE602004009200T2
(de)
|
2003-08-12 |
2008-07-10 |
F. Hoffmann-La Roche Ag |
Tetrahydrochinazolinderivate als cfr-antagonisten
|
|
BRPI0414238A
(pt)
|
2003-09-09 |
2006-10-31 |
Ono Pharmaceutical Co |
antagonistas de crf e compostos heterobicìclicos
|
|
WO2005039564A1
(en)
|
2003-10-02 |
2005-05-06 |
Vertex Pharmaceuticals Incorporated |
Phthalimide compounds useful as protein kinase inhibitors
|
|
KR101013932B1
(ko)
*
|
2003-10-21 |
2011-02-14 |
워너-램버트 캄파니 엘엘씨 |
Ｎ-[(ｒ)-2,3-디히드록시-프로폭시]-3,4-디플루오로-2-(2-플루오로-4-요오도페닐아미노)-벤자미드 다형체 형태
|
|
JP2007512364A
(ja)
|
2003-11-21 |
2007-05-17 |
アレイ バイオファーマ、インコーポレイテッド |
Ａｋｔプロテインキナーゼインヒビター
|
|
JP5213229B2
(ja)
|
2004-04-23 |
2013-06-19 |
エグゼリクシス， インコーポレイテッド |
キナーゼ調節因子および使用方法
|
|
WO2005105780A2
(en)
|
2004-04-28 |
2005-11-10 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
|
WO2006000589A1
(en)
|
2004-06-28 |
2006-01-05 |
Altana Pharma Ag |
4,6-disubstituted pyrimidines and their use as protein kinase inhibitors
|
|
US20060025074A1
(en)
|
2004-07-30 |
2006-02-02 |
Chih-Ming Liang |
Bluetooth-based headset
|
|
TWM266655U
(en)
|
2004-09-23 |
2005-06-01 |
Blueexpert Technology Corp |
Bluetooth earphone device capable of wirelessly receiving and transmitting stereo sound signal and digital information signal
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
|
CA2590961C
(en)
|
2004-12-28 |
2013-11-26 |
Exelixis, Inc. |
[1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
JP2008531542A
(ja)
|
2005-02-24 |
2008-08-14 |
ファイザー・プロダクツ・インク |
抗癌剤として有用な二環式複素芳香族誘導体
|
|
WO2006094230A2
(en)
|
2005-03-03 |
2006-09-08 |
The Burnham Institute For Medical Research |
Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered thereby
|
|
WO2006127587A1
(en)
|
2005-05-20 |
2006-11-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
AR054485A1
(es)
|
2005-06-21 |
2007-06-27 |
Cancer Rec Tech Ltd |
ARIL-ALQUILAMINAS Y HETEROARIL-ALQUILAMINAS COMO INHIBIDORES DE PROTEINA QUINASA A Y B, UN PROCESO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES ORIGINADAS EN EL CRECIMIENTO ANORMAL DE LA
|
|
CA2622755C
(en)
*
|
2005-10-07 |
2017-01-31 |
Exelixis, Inc. |
Azetidines as mek inhibitors
|
|
EP1948658A1
(en)
|
2005-10-13 |
2008-07-30 |
Glaxo Group Limited |
Pyrrolopyrimidine derivatives as syk inhibitors
|
|
AR056893A1
(es)
|
2005-12-28 |
2007-10-31 |
Takeda Pharmaceutical |
Compuestos heterociclicos fusionados y no fusionados, antagonistas de receptores mineralocorticoides
|
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
RU2008152171A
(ru)
|
2006-07-05 |
2010-08-10 |
Интермьюн, Инк. (Us) |
Новые ингибиторы вирусной репликации гепатита с
|
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
BRPI0714062A2
(pt)
|
2006-07-06 |
2012-12-18 |
Glaxo Group Ltd |
n-fenil-metil-5-oxo-prolina-2-amidas substituìdas como antagonistas do receptor da p2x, e os seus métodos de uso
|
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
SI2049500T1
(sl)
|
2006-07-06 |
2012-01-31 |
Array Biopharma Inc |
Ciklopenta (d) pirimidini kot AKT protein kinazni inhibitorji
|
|
WO2008006039A1
(en)
|
2006-07-06 |
2008-01-10 |
Array Biopharma Inc. |
Dihydrothieno pyrimidines as akt protein kinase inhibitors
|
|
GB0613518D0
(en)
|
2006-07-06 |
2006-08-16 |
Phytopharm Plc |
Chemical compounds
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
|
AU2007334402B2
(en)
|
2006-12-14 |
2014-02-13 |
Exelixis, Inc. |
Methods of using MEK inhibitors
|
|
PE20090678A1
(es)
*
|
2007-09-12 |
2009-06-27 |
Genentech Inc |
Combinaciones de compuestos inhibidores de fosfoinositida 3-quinasa y agentes quimioterapeuticos y los metodos de uso
|
|
CA2729914A1
(en)
|
2008-07-11 |
2010-01-14 |
Novartis Ag |
Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway
|
|
WO2010014939A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Genentech, Inc. |
Pyrimidine compounds, compositions and methods of use
|
|
ES2527625T3
(es)
*
|
2009-09-23 |
2015-01-27 |
Glaxosmithkline Llc |
Combinación farmacéutica
|